Premium
Estimation of the prevalence of orally treated diabetes in France using a pharmacoepidemiologic approach: comparison between 1981 and 1992
Author(s) -
VauzelleKervroëdan F.,
Forhan A.,
Guillemot D.,
Sermet C.,
Maison P.,
Balkau B.,
Eschwège E.
Publication year - 1999
Publication title -
pharmacoepidemiology and drug safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.023
H-Index - 96
eISSN - 1099-1557
pISSN - 1053-8569
DOI - 10.1002/(sici)1099-1557(199912)8:7<519::aid-pds458>3.0.co;2-y
Subject(s) - medicine , diabetes mellitus , life expectancy , demography , pharmacoepidemiology , public health , population , estimation , environmental health , gerontology , pediatrics , endocrinology , nursing , management , sociology , medical prescription , economics , pharmacology
Purpose Non‐insulin‐dependent diabetes may become a public health problem in the next decade, given the increasing life expectancy of populations and because the baby‐boom generation will reach the age at risk. Moreover a modification of the diagnostic criteria may increase the number of diabetic patients. We studied the evolution of diabetes prevalence. Methods A non‐specific household survey, performed every 10 years was used. Patients who bought an oral antidiabetic drug during these studies were classified as diabetics. Results In 1980–81 and 1991–92 the crude diabetes prevalences were not significantly different even if there was a trend to increase (1.27% and 1.41%, respectively). When the 1980–81 prevalence was standardized to the age distribution of the 1991–92 sample, the trend disappeared (prevalence 1980–81:1.35%). Conclusion There was no increase in an individual's risk of diabetes. However the crude prevalence tended to increase because of the changing age structure of the population. On‐going studies are needed to follow the prevalence of diabetes during the next decade. Copyright © 1999 John Wiley & Sons, Ltd.